Table 1.
Pre-Dex |
Post-Dex |
|||||||
---|---|---|---|---|---|---|---|---|
Parameter measured | Mean | StDev | n = | Mean | StDev | n = | % change | p value |
CD3 T cells per μL | 848 | 401 | 30 | 370 | 207 | 32 | −56.3 | <0.001 |
CD4 T cells per μL | 551 | 199 | 31 | 236 | 149 | 33 | −57.2 | <0.001 |
CD4 % of CD3 T cells | 65.4 | 10.8 | 32 | 57.6 | 12.8 | 35 | −11.9 | <0.001 |
CD8 T cells per μL | 246 | 212 | 30 | 124 | 103 | 31 | −49.8 | <0.001 |
CD8 % of CD3 T cells | 27.1 | 10.3 | 32 | 33.7 | 13.4 | 34 | 24.4 | <0.001 |
CD4 to CD8 T cell ratio | 3.0 | 1.9 | 32 | 2.3 | 1.7 | 34 | −25.3 | <0.001 |
Tregs per μL | 24.0 | 11.9 | 31 | 9.7 | 6.5 | 33 | −59.3 | <0.001 |
Treg % of CD4+ T cells | 4.2 | 1.3 | 35 | 4.2 | 1.4 | 35 | −1.2 | 0.755 |
Ki67+ % of Tregs | 21.3 | 6.9 | 35 | 38.3 | 13.0 | 35 | 79.5 | <0.001 |
Ki67+ % of non-Treg CD4 T cells | 3.1 | 1.4 | 35 | 4.8 | 2.4 | 35 | 53.1 | <0.001 |
ICOS+ % of Tregs | 35.2 | 15.3 | 35 | 46.7 | 15.7 | 35 | 32.4 | <0.001 |
ICOS+ % of non-Treg CD4 T cells | 6.5 | 5.0 | 35 | 7.0 | 5.2 | 35 | 8.4 | 0.121 |
effector (CD38hiHLA-DRhi) CD8 T cells per μL | 4.4 | 3.9 | 30 | 2.3 | 1.3 | 31 | −46.5 | 0.003 |
effector % of CD8 T cells | 1.9 | 1.5 | 35 | 2.5 | 1.9 | 35 | 33.4 | <0.001 |
Bcl2lo % of effector CD8 T cells | 66.5 | 17.0 | 35 | 64.1 | 18.1 | 35 | −3.6 | 0.293 |
Ki67+ % of effector CD8 T cells | 63.3 | 17.2 | 35 | 69.7 | 17.1 | 35 | 10.0 | 0.009 |
ICOS+ % of effector CD8 T cells | 27.9 | 14.2 | 35 | 28.8 | 13.7 | 35 | 3.3 | 0.608 |
Bcl2lo % of CD8 T cells | 3.8 | 2.2 | 35 | 3.6 | 2.6 | 35 | −5.9 | 0.527 |
Ki67+ % of CD8 T cells | 2.0 | 1.5 | 35 | 2.9 | 2.0 | 35 | 45.7 | 0.001 |
ICOS+ % of CD8 T cells | 2.1 | 3.8 | 35 | 1.7 | 1.9 | 35 | −20.7 | 0.353 |
CD8 T cells to Treg ratio | 10.7 | 6.3 | 30 | 17.0 | 13.5 | 31 | 59.2 | <0.001 |
DC (HLA-DR+ Lin-) % of PBMC | 0.4 | 0.2 | 15 | 0.3 | 0.2 | 15 | −31.4 | 0.035 |
HLA-DR+ lin- BDCA1+ % of total PBMC | 0.159 | 0.120 | 15 | 0.085 | 0.102 | 15 | −46.3 | 0.024 |
HLA-DR+ lin- BDCA2+ % of total PBMC | 0.147 | 0.095 | 15 | 0.048 | 0.053 | 15 | −67.2 | 0.001 |
HLA-DR+ lin- BDCA3+ % of total PBMC | 0.028 | 0.019 | 15 | 0.022 | 0.015 | 15 | −21.9 | 0.279 |
BDCA1+ % of DC | 35.6 | 19.8 | 15 | 21.8 | 18.8 | 15 | −38.8 | 0.023 |
BDCA2+ % of DC | 32.6 | 13.7 | 15 | 17.2 | 14.4 | 15 | −47.1 | 0.008 |
BDCA3+ % of DC | 5.6 | 2.4 | 15 | 12.0 | 8.4 | 15 | 116.2 | 0.003 |
BDCA1+ Dc to BDCA2+ DC ratio | 2.1 | 2.6 | 15 | 2.2 | 2.3 | 15 | 5.3 | 0.884 |
BDCA1+ DC CD40 MFI | 43.0 | 32.3 | 15 | 75.6 | 58.3 | 15 | 75.7 | 0.005 |
BDCA1+ DC CD83 MFI | 78.7 | 34.1 | 15 | 64.8 | 27.8 | 15 | −17.7 | 0.188 |
BDCA1+ DC CD80 MFI | 110 | 42 | 15 | 135 | 69 | 15 | 22.7 | 0.036 |
BDCA2+ DC CD40 MFI | 27.0 | 24.1 | 15 | 17.0 | 19.3 | 15 | −37.0 | 0.138 |
BDCA2+ DC CD83 MFI | 34.7 | 13.8 | 15 | 35.8 | 12.7 | 15 | 2.9 | 0.831 |
BDCA2+ DC CD80 MFI | 129 | 25 | 15 | 241 | 440 | 15 | 86.4 | 0.344 |
BDCA3+ DC CD40 MFI | 29.5 | 70.9 | 15 | 25.2 | 84.3 | 15 | −14.5 | 0.744 |
BDCA3+ DC CD83 MFI | 46.6 | 58.2 | 15 | 37.5 | 30.2 | 15 | −19.5 | 0.408 |
BDCA3+ DC CD80 MFI | 198 | 45 | 15 | 229 | 96 | 15 | 15.8 | 0.118 |
List of leukocyte parameters retrospectively examined for changes in response to Dex. For timing of blood sample withdrawal and Dex administration, see Figure 1A. “% change” refers to difference in mean values between “pre-Dex” and “post-Dex” timepoints. P values were calculated using the paired t-test.